JohnDosterMD

Oncology • Anderson, SC

anderson area cancer center

Join to view full profile

Dr. Doster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Doster's full profile

Already have an account?

Office
2000 E Greenville St
Ste 5000
Anderson, SC 29621
Phone+1 864-224-5765

Fax+1 864-224-1449

Education & Training

Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1991 - 1994
Medical College of Georgia at Augusta UniversityClass of 1991

Certifications & Licensure

SC State Medical License 1996 - 2025
NC State Medical License 1995 - 1999
GA State Medical License 1996 - 1997
American Board of Internal Medicine Medical Oncology

Clinical Trials

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil Start of enrollment: 2017 May 30
Completed
Phase 3
TR(ACE) Assay Clinical Specimen Study Start of enrollment: 2016 Sep 01
Unknown status
Oxybutynin Chloride in Managing Hot Flashes Start of enrollment: 2016 Dec 09
Completed
Phase 3
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

13 citations
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)
Katherine D. Crew, Garnet L. Anderson, Dawn L. Hershman, Mary Beth Terry, Parisa Tehranifar
Cancer Prevention Research. 2019-07-01
1 citations
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812.
Julia E McGuinness, Garnet L Anderson, Simukayi Mutasa, Dawn L Hershman, Mary Beth Terry
JNCI Cancer Spectrum. 2024-07-01